Our CSO and President, R&D, Hal Barron joined John Carroll from Endpoints News at the Biotechnology Innovation Conventions’ virtual summit to discuss R&D leadership during the #COVID19 pandemic. Hal joined a panel of top R&D execs to discuss how they've reorganized global teams, tapped new programs as a priority to fight Covid-19 and are planning for the future after the pandemic has passed.
Necessity is the mother of innovation."
Watch the full panel discussion
Curious to know how we’re fighting COVID-19 at GSK and across the industry? Hal Barron, our CSO and President, R&D shares more with John Carrol of Endpoints News and other R&D executives across the industry.
Delivering potentially transformational medicines through R&D innovation in Oncology
Axel Hoos, SVP, Oncology R&D, explains how GSK is driving innovation in Oncology R&D